SM
TNDM icon

Sabby Management’s Tandem Diabetes Care TNDM Stock Holding History

Sabby Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-27,487
Closed -$65K – 181
2017
Q4 		$65K Buy
+27,487
New +$86.3K 0.01% 137

Other funds holding TNDM

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

Sabby Management's TNDM Position: Q1 2018 in Review

Sabby Management sold out of Tandem Diabetes Care (TNDM) in Q1 2018, closing a stake of 27,487 shares — an estimated $65K sold.

Sabby Management first reported a position in TNDM in Q4 2017 and held it in 1 quarter. The position peaked at $65K in Q4 2017. 75 funds tracked by Wall St. Rank hold TNDM as of Q1 2018.

  • Sabby Management reported no remaining Tandem Diabetes Care position as of Q1 2018 after selling out during the quarter.
  • Sabby Management sold 27,487 Tandem Diabetes Care shares in Q1 2018, an estimated $65K.
  • Sabby Management first reported a position in Tandem Diabetes Care in Q4 2017 and held it in 1 quarter.
  • Sabby Management's Tandem Diabetes Care position peaked at $65K in Q4 2017.
  • 75 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2018.

Based on Sabby Management's 13F filing for Q1 2018, filed 15 May 2018.